When responding to an ad for a job caring for patient-detainees along the US southern border, applicants should anticipate the need to navigate dual loyalties.

Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.

Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research.

Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes.

Editorial fellow Dr Ariel Wampler describes what few know about material and device regulation, and Dr Adriane Fugh-Berman explains why we should ask more questions about device representatives’ intraoperative roles during implantations.

Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?"

Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.

A just culture perspective suggests that punitive responses to those who err should be reserved for those who have willfully and irremediably caused harm.

How should physicians researching life-sustaining technologies consider their duties to enrolled subjects?

As larger organizations become more influential in the health care sector, the Code can help physicians navigate those organizations’ influence on their practices.